152.47 -1.89 (-1.22%)

2.1M XNYS Volume

XNYS 15 Apr, 2025 10:02 AM (EDT)

Estimates Beat
Johnson & Johnson's Q1 revenue of $21.9 bn beats estimates by 1.5% due to higher cancer drug sales See details

Detailed Stock Analysis for Johnson & Johnson with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in